Geron share price logo

Geron

NASDAQ: GERN

Small Cap

$1.52

as on

Geron Stock Performance

as on August 25, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $1.44
    $1.55
    downward going graph

    5.26%

    Downside

    1.97%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.04
    $2.01
    downward going graph

    31.58%

    Downside

    32.24%

    Upside

    downward going graph

Geron share price movements today

Previous Close
$1.52
Open
$1.53
Volume
10.9M
Market Cap
$943.0M
Day's Low - High
$1.44 - $1.55
52 Week Low - High
$1.04 - $2.01

Geron Historical Returns

1 Month Return
+ 2.08 %
3 Month Return
+ 13.95 %
1 Year Return
+ 1.38 %
3 Year Return
-42.35 %
5 Year Return
+ 14.84 %

Geron Stock Fundamentals & Key Indicators

Check Geron market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$943.0M

EPS (TTM)

-0.02

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

-2.38

EBITDA

-34.8M

Revenue (TTM)

204.6M

Profit Margin

-33.05%

Return On Equity TTM

-28.28%

Geron vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Geron with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$943.0M14.84%NA-33.05%NA
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$25.3B-84.24%-7.98-12.57%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for Geron Stock including INR - Dollar returns

The Geron stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Geron investment value today

Current value as on today

₹1,14,551

Returns

₹14,551

(+14.55%)

Returns from Geron Stock

₹4,828 (+4.83%)

Dollar Impact

₹9,724 (+9.72%)

Analyst Recommendation on Geron Stock

Based on 4 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 4 analysts, 75% of analysts recommend a 'BUY' rating for Geron. Average target price of $4.25

Geron Share Price Target

Get share price movements and forecasts by analysts on Geron.

What analysts predicted

64.24%UPSIDE

Target Price

$4.25

Current Price

$1.52

Analyzed by

4 Analysts

Target

$4.25

Geron target price $4.25, a slight upside of 64.24% compared to current price of $1.52. According to 4 analysts rating.

Indian Investors' Interest in Geron Stock

Search interest for Geron Stock has increased by 22% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:22% versus previous 30 day period

Geron Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
0
0
28
47
39
49
47
48
51
57
Gross Profit
0
0
27
46
38
47
25
46
50
48
Operating Income
-56
-69
-28
-20
-16
-12
-13
-10
0
-12
EBITDA
-51
-63
-23
-16
-11
-7
-9
-23
3
-12
Interest Expense
3
3
3
8
8
8
8
7
7
7
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-55
-67
-26
-25
-19
-16
-18
-31
-3
-16
Income Tax Expense
0
-
-26
-
-
-
-
-
-
-
Net Income
-55
-67
-26
-25
-19
-16
-18
-31
-3
-16
Net Profit Margin
-18220.39%
-7639.80%
-93.55%
-53.33%
-50.08%
-33.39%
-39.02%
-64.86%
-7.03%
-29.02%

Geron Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
6
1
1
0
0
1
0
0
76
183
Gross Profit
-8
-7
-11
0
-49
1
0
0
75
179
Operating Income
-30
-29
-31
-72
-76
-113
-138
-193
-173
-53
EBITDA
-30
-29
-26
-71
-76
-111
-134
-174
-154
-51
Interest Expense
0
0
-
-
0
3
6
8
18
32
Depreciation
-
0
0
0
0
0
0
1
1
1
Income Before Tax
-29
-27
-27
-68
-75
-116
-141
-184
-174
-85
Income Tax Expense
1
1
4
-4
0
4
0
0
-
-
Net Income
-29
-27
-27
-63
-75
-116
-141
-184
-174
-85
Net Profit Margin
-479.34%
-2621.22%
-2534.43%
-13815.43%
-29888.14%
-8335.39%
-23808.89%
-77690.72%
-226.73%
-46.65%

Geron Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-67
-26
-25
-19
-16
-18
-28
-3
-16
Operating Cash Flow
-53
-58
-43
-47
-27
-13
-22
-62
-15
Investing Cash Flow
-36
0
-103
52
20
13
21
51
8
Financing Cash Flow
16
3
166
0
1
0
0
2
1
Change in Cash
-72
-55
18
4
-6
0
0
-8
-6

Geron Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-27
-27
-68
-75
-116
-141
-184
-174
-85
Operating Cash Flow
-20
-21
-43
-66
-95
-127
-167
-218
-111
Investing Cash Flow
22
-77
27
-105
71
62
-180
-106
107
Financing Cash Flow
1
92
19
168
48
87
362
334
2
Change in Cash
3
-5
3
-3
24
21
13
9
-1

Mutual Funds that own Geron Stock

Check out the Mutual Funds with significant holdings in Geron.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
4.047914%
26006775
VANGUARD EXPLORER FUND
1.583659%
10174592
Fidelity Select Portfolios
1.010549%
6492512
Legg Mason Partners Investment Trust
0.983092%
6316110
Fidelity Salem Street Trust
0.917162%
5892524

Global Institutional Holdings in Geron

Funds
Holdings
Peter Kolchinsky
9.93%
Vanguard
4.97%
iShares
4.33%
SPDR
3.74%
Xtrackers
1.42%

Geron News & Key Events

  • img

    Today's Timeline - 14 July

    Tue, 04:04 PM

    -

    Geron grants stock options for 690,000 shares to eight new employees as inducement for employment.

    Wed, 01:56 AM

    -

    Geron grants 1.7M-share stock option to new Chief Business Officer Chinmaya Rath as employment inducement.

Insights on Geron

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, GERN stock has moved up by 18.8%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 47.22M → 57.47M (in $), with an average increase of 6.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 487.2% return, outperforming this stock by 480.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 532.0% return, outperforming this stock by 570.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -3.64M → -16.68M (in $), with an average decrease of 358.0% per quarter

About Geron

Geron Corporation, a commercial-stage biopharmaceutical company, focuses on the development of therapeutics products for oncology. The company's product pipeline includes RYTELO, a telomerase inhibitor for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia; IMerge which is in Phase 3 clinical trial for the treatment of lower-risk myelodysplastic syndromes; IMpactMF that is in Phase 3 for the treatment of relapsed/refractory myelofibrosis; Impress which is in Phase 2 clinical trial to treat higher risk myelodysplastic syndromes and acute myeloid leukemia (AML); IMproveMF which is in Phase 1 clinical trial for the treatment of frontline myelofibrosis; and IMAGINE which is in phase 1/2 clinical trial for the treatment of relapsed/refractory AML. Geron Corporation was incorporated in 1990 and is headquartered in Foster City, California.
OrganisationGeron
Headquarters919 East Hillsdale Boulevard, Foster City, CA, United States, 94404
IndustryBiotechnology
CEOMr. Harout Semerjian
E-voting on sharesClick here to vote

Key Management of Geron

Name

Title

Mr. Shanthakumar Tyavanagimatt

Senior VP & Chief Technical Officer

Mr. Timothy Williams J.D.

Executive VP, Chief Legal Officer & Corporate Secretary

Ms. Aron Feingold

Vice President of Investor Relations & Corporate Communications

Ms. Shannon T. Odam

Executive VP & Chief People Officer

Mr. Harout Semerjian

CEO, President & Director

Ms. Michelle J. Robertson

EVP, CFO, Treasurer and Principal Financial & Accounting Officer

Dr. Joseph Emile Eid M.D.

Executive VP of Research & Development and Chief Medical Officer

Mr. Ahmed ElNawawi

Executive VP & Chief Commercial Officer

Ms. Dawn Schottlandt CFA

Senior Vice President of Investor Relations & Corporate Affairs

Mr. Bryan Ridgell

Senior VP of Portfolio & Project Management and Chief of Staff

FAQs

What is Geron share price today?

Geron share price today is $1.52 as on at the close of the market. Geron share today touched a day high of $1.55 and a low of $1.44.

What is the 52 week high and 52 week low for Geron share?

Geron share touched a 52 week high of $2.01 on and a 52 week low of $1.04 on . Geron stock price today i.e. is closed at $1.52,which is 24.38% down from its 52 week high and 46.15% up from its 52 week low.

What is Geron's market capitalisation today?

Geron market capitalisation is $0.00T as on .

How to invest in Geron Stock (GERN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Geron on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Geron Shares that will get you 0.9868 shares as per Geron share price of $1.52 per share as on August 25, 2026 at 1:29 am IST.

What is the minimum amount required to buy Geron Stock (GERN) from India?

Indian investors can start investing in Geron (GERN) shares with as little as ₹95.735 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.35 in Geron stock (as per the Rupee-Dollar exchange rate as on ). Based on Geron share’s latest price of $1.52 as on August 25, 2026 at 1:29 am IST, you will get 6.5789 shares of Geron. Learn more about fractional shares .

What are the returns that Geron has given to Indian investors in the last 5 years?

Geron stock has given 14.84% share price returns and 29.09% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?